KLRG1在人类CD4+ T细胞抗结核免疫中的作用
研究比较结核患者与对照者CD4+ T细胞KLRG1表达,发现活动性结核患者KLRG1表达显著升高;KLRG1+CD4+ T细胞在结核分枝杆菌刺激后分泌干扰素γ、白细胞介素2和肿瘤坏死因子α的能力更强,但寿命更短、凋亡率更高;阻断KLRG1信号可增强干扰素γ和白细胞介素2分泌,该效应依赖Akt信号通路。
要点
- 活动性结核患者CD4+ T细胞KLRG1表达较健康对照和无结核患者显著升高。
- KLRG1+CD4+ T细胞受结核分枝杆菌刺激后分泌干扰素γ、白细胞介素2和肿瘤坏死因子α的能力显著强于KLRG1阴性CD4+ T细胞。
- 阻断KLRG1信号可显著增强干扰素γ和白细胞介素2分泌,且不影响细胞凋亡或增殖,该效应由Akt信号通路介导。
核心结论
- 结核分枝杆菌感染驱动CD4+ T细胞以终末分化状态获得增强的效应功能,该功能受KLRG1通过KLRG1/Akt信号通路 restrained。
研究设计与样本
- 设计结核患者队列,在有或无抗体阻断条件下测定KLRG1+CD4+ T细胞的表达谱和功能。
主要发现
- 活动性结核患者CD4+ T细胞KLRG1表达较健康对照和无结核患者显著升高。
- 结核分枝杆菌特异性刺激后,KLRG1表达CD4+ T细胞分泌干扰素γ、白细胞介素2和肿瘤坏死因子α的能力显著强于KLRG1阴性CD4+ T细胞,并伴随调节性T细胞比例降低和Akt信号增强。
- KLRG1表达CD4+ T细胞寿命更短,与凋亡率更高相关,但增殖反应相似。
- 阻断KLRG1信号显著增强干扰素γ和白细胞介素2分泌,不影响细胞凋亡或增殖。
- 加入特异性Akt抑制剂可阻止细胞因子反应增强,提示Akt信号通路参与。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: KLRG1 is a marker of terminally differentiated CD8+ T cells in viral infection, but its role in human Mycobacterium tuberculosis infection remains elusive. METHODS: A set of cohorts of patients with tuberculosis was designed, and the expression profiles and functions of KLRG1+CD4+ T cells were determined with and without antibody blocking. RESULTS: KLRG1 expression on CD4+ T cells was significantly increased in patients with active tuberculosis, compared with healthy controls and patients without tuberculosis. Upon M. tuberculosis-specific stimulation, the ability to secrete interferon γ, interleukin 2, and tumor necrosis factor α was significantly greater in KLRG1-expressing CD4+ T cells than in their KLRG-negative counterparts and was accompanied by a decreased proportion of regulatory T cells and increased Akt signaling. However, KLRG1-expressing CD4+ T cells had a shorter life-span, which was associated with a higher apoptosis rate but a similar proliferative response. Blockade of KLRG1 signaling significantly enhanced interferon γ and interleukin 2 secretion without affecting either cell apoptosis or multiplication. Addition of a specific Akt inhibitor prevented this increased cytokine response, implicating the Akt signaling pathway. CONCLUSIONS: Our study delineated the profile of KLRG1+CD4+ T cells in patients with tuberculosis and suggests that M. tuberculosis infection drives CD4+ T cells to acquire increased effector function in a terminally differentiated state, which is restrained by KLRG1 via KLRG1/Akt signaling pathway.
引用
- Hu Z, Zhao HM, Li CL, et al. The Role of KLRG1 in Human CD4+ T-Cell Immunity Against Tuberculosis. J Infect Dis. 2018. PMID: 29373700. doi:10.1093/infdis/jiy046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。